Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MEK/MAPK inhibitors.
Dy G. Dy G. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S474-5. doi: 10.1097/01.JTO.0000391372.94376.37. J Thorac Oncol. 2010. PMID: 21102245 Free article. No abstract available.
SRC inhibitors.
Dy G. Dy G. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S466-7. doi: 10.1097/01.JTO.0000391368.41011.81. J Thorac Oncol. 2010. PMID: 21102241 Free article. No abstract available.
Novel taxanes/epothilones.
Dy G. Dy G. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S490-1. doi: 10.1097/01.JTO.0000391379.94307.d1. J Thorac Oncol. 2010. PMID: 21102252 Free article. No abstract available.
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.
Adjei AA, Salavaggione OE, Mandrekar SJ, Dy GK, Ziegler KL, Endo C, Molina JR, Schild SE, Adjei AA. Adjei AA, et al. J Thorac Oncol. 2010 Sep;5(9):1346-53. doi: 10.1097/JTO.0b013e3181ec18c4. J Thorac Oncol. 2010. PMID: 20651609 Free PMC article. Clinical Trial.
Topotecan and paclitaxel in previously treated patients with relapsed small cell lung cancer: phase II trial of the North Central Cancer Treatment Group.
Dy GK, Jett JR, Geoffroy FJ, Krewer KD, Tazelaar H, Maurer M, Rowland K, Mailliard J, Krook J, Dakhil S, Kutteh L, Kugler J, Wender D. Dy GK, et al. J Thorac Oncol. 2006 Mar;1(3):211-7. doi: 10.1016/s1556-0864(15)31570-7. J Thorac Oncol. 2006. PMID: 17409859 Free article. Clinical Trial. No abstract available.
A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528.
Dy GK, Mandrekar SJ, Nelson GD, Meyers JP, Adjei AA, Ross HJ, Ansari RH, Lyss AP, Stella PJ, Schild SE, Molina JR, Adjei AA. Dy GK, et al. J Thorac Oncol. 2013 Jan;8(1):79-88. doi: 10.1097/JTO.0b013e318274a85d. J Thorac Oncol. 2013. PMID: 23232491 Free PMC article. Clinical Trial.
196 results